UCL Biochemical Engineering, Pilot Plant Week 2014, Group 1- Stem Cells
Nothing - Cat Empire http://www.youtube.com/watch?v=MDhil5vSsFE With Thanks, to UCL Biochemical Engineering.
By: UCL BiochemEng
Read more:
UCL Biochemical Engineering, Pilot Plant Week 2014, Group 1- Stem Cells - Video
Cloning: 1st Place Sci Vis at Florida TSA State Conference
This video explores both reproductive and therapeutic cloning, from somatic cell nuclear transfer to modern concerns about stem cells. All scenes are origina...
By: Adrian Traviezo
Continue reading here:
Cloning: 1st Place Sci Vis at Florida TSA State Conference - Video
Medeniyet Konferansn "nsan Kanser Kk Hcreleri (Human Cancer Stem Cells: Fact or Fiction)"
12 ubat 2014 tarihinde niversitemiz Gztepe-Kuzey Yerlekesinde gerekleen konferansta Dr. James A. Radosevich #39;in, "nsan Kanser Kk Hcreleri (Human Canc...
By: MU NVERSTES
Continue reading here:
Medeniyet Konferansn "nsan Kanser Kk Hcreleri (Human Cancer Stem Cells: Fact or Fiction)" - Video
Are stem cells from osteoarthritis patients able to differentiate
http://www.arthritistreatmentcenter.com Are stem cells in patients with osteoarthritis less able to differentiate? J Mary Murphy and colleagues published an ...
By: Nathan Wei
Original post:
Are stem cells from osteoarthritis patients able to differentiate - Video
Atheist Community of San Jose: Uta Grieshammer on The Remarkable Powers of Stem Cells
Did you know that without stem cells you would not be able to absorb any food, you wouldn #39;t have any skin and there would be no blood coursing through your v...
By: SanJoseAtheists
Go here to see the original:
Atheist Community of San Jose: Uta Grieshammer on The Remarkable Powers of Stem Cells - Video
What is Embryonic Stem Cells? (Chinese)
Like us at https://www.facebook.com/puredeerpurtier.
By: purtierbecca
Here is the original post:
What is Embryonic Stem Cells? (Chinese) - Video
Cambridge News Follow us on
Sunday 23 Feb 2014 10:30 AM
Written byELEANOR DICKINSON
Sufferers of serious brain diseases could one day be helped by stem cell treatments , according to scientists at Cambridge University.
Scientists at the University hope to be able to use the regenerative power of stem cells to treat major brain conditions such as Parkinsons and Huntingtons disease.
Their findings are expected to be revealed at the Cambridge Festival of Science next month.
Robin Franklin, the newly appointed Professor of Stem Cell Medicine, will be discussing his research into central nervous system regeneration and the possibility of treating multiple sclerosis.
He said: The brain, although capable of unmatched feats of adaptability, is generally considered to be an organ that is very poor at mending itself after injury.
However, one particular type of brain cell, called the oligodendrocyte the cell that makes the myelin wrapping around nerve fibres can be regenerated when lost in disease by the brains own stem cells.
By studying in the laboratory how brain stem cells generate new oligodendrocytes it has been possible to identify ways in which this important regenerative process might be achieved in the clinic, offering the
More:
Stem cells to fight brain diseases say Cambridge scientists
Arthritic knees treated with stem cells by Dr Harry Adelson - 18 months after treatment
Linda discusses her outcome of the stem cell treatment she received from Dr Harry Adelson for her arthritic knees.
By: Harry Adelson, N.D.
See original here:
Arthritic knees treated with stem cells by Dr Harry Adelson - 18 months after treatment - Video
Spontaneous Contracting Former Stem Cells
By: Michelle Sener
See the original post:
Spontaneous Contracting Former Stem Cells - Video
Synovium as a source of stem cells for osteoarthritis treatment
http://www.stemcellsarthritistreatment.com What is the best source of stem cells for osteoarthritis treatment? This next item may provide the answer. Sakaguc...
By: Nathan Wei
More here:
Synovium as a source of stem cells for osteoarthritis treatment - Video
CLINICell Stem Cell Therapy for Knee Meniscus Tear 1 year Follow-Up
Stem cell therapy for knee post operative interview. This patient came in with a knee meniscus tear and one year after his initial procedure patient is pain ...
By: ClinicellTech
Go here to read the rest:
CLINICell Stem Cell Therapy for Knee Meniscus Tear 1 year Follow-Up - Video
Stem Cell Therapy - Studies That Support Regenerative Therapy (Regenexx)
Dr Robert Wagner of Stem Cell ARTS discusses the research and science behind advanced regenerative medicine therapies and the track record of treating knee, ...
By: StemCell ARTS
Read more:
Stem Cell Therapy - Studies That Support Regenerative Therapy (Regenexx) - Video
(See correction at end of story).
Supporters of Californias multibillion-dollar stem cell program plan to ask for $5 billion more to bring the fruits of research to patients.
Robert Klein, a leader of the 2004 initiative campaign that established the program, said Thursday hes going to be talking with California voters about the proposal. If the public seems receptive, backers will work to get an initiative on the 2016 ballot to extend funding for the California Institute for Regenerative Medicine
Klein outlined the proposal Thursday at UC San Diego Moores Cancer Center, during a symposium on how to speed research to patient care.
Since cancer cells and stem cells share some underlying characteristics, CIRM has funded research into those similarities, including the work of Moores Cancer Center researchers David Cheresh and Catriona Jamieson.
Klein said supporters, including researchers, patients and patient advocates need to educate the public about the benefits of funding stem cell research, and the results to date. A former chairman of CIRM, Klein is no longer formally affiliated with the agency but continues to support its work.
No stem cell treatments funded by CIRM have been approved, but patients have benefited in other ways. CIRM-funded research into cancer stem cells led to a clinical trial of a drug that caused remission of a bone marrow cancer in Sandra Dillon, a patient of Jamiesons. Moreover, California has vaulted into prominence in regenerative medicine, and the field has also provided a new growth engine for the states large biotech industry.
Though CIRM has been praised for advancing quality research, it has been criticized for being slow to fund commercialization by life science companies.
In addition, CIRM has been criticized for a lack of transparency and conflicts of interest in how it awards grants. The agency revamped its policies last year to forbid institutional members of its governing oversight committee from voting on proposals to fund research at any other institution. This was done to prevent the appearance of horse-trading among committee members.
California voters set aside $3 billion in bond money for CIRM in 2004 under Proposition 71. The money is expected to run out around 2017, so Klein and other supporters have been preparing to go back to the public. The amount paid back will be $6 billion, including interest over the life of the bonds, Klein noted. So the $5 billion for CIRM would require a $10 billion bond measure.
Read the original post:
$5 billion initiative proposed for stem cell research
Duke University Health SystemDr. Victor J. Dzau, the current president and CEO of Duke University Health System
Dr. Victor J. Dzau, the current president and CEO of Duke University Health System and chancellor for health affairs at Duke University, has been appointed to a six-year term as the next president of the Institute of Medicine (IOM), effective July 1, 2014. Dr. Dzau will take over the lead role from Dr. Harvey Fineberg, who served in the position for twelve years.
Dr. Dzau began his career in medicine as a cardiologist, having previously taught at Harvard Medical School and served as chair of the department of medicine. He also worked at Brigham and Womens Hospital as the director of research. His ongoing award-winning research has been key in the development of cardiovascular drugs, as well as techniques to repair tissue damage from heart attacks and heart disease using stem cell therapies.
Dr. Eugene Braunwald, often called the father of modern cardiology and a professor of medicine at Harvard Medical School, has known Dr. Dzau for more than 40 years and worked with him at many different stages of his career at Brigham and Womens Hospital and Partners Healthcare. In an interview Wednesday he called the upcoming IOM president a force of nature.
He is what I would call a talented, quadruple threat. A great physician, inspiring teacher, and a very creative scientist, said Dr. Braunwald, who trained Dzau when he was a resident at Brigham and Womens and continued to work with him on cardiovascular research when Dr. Dzau became chief resident, and then faculty at Harvard Medical School. The quadruple threat is that he also sees the larger picture. Hes interested in areas of medicine that most academic physicians have stayed away from. His work and ideas in global and community-based medicine have left an important heritage at each institution where hes worked.
After nearly a decade at Duke, Dr. Dzaus leadership has been credited with the launch of a number of innovative and global-focused medical institutions, including the Duke-National University of Signapore Graduate Medical School, Duke Global Health Institute, Duke Institute for Health Innovation, Duke Cancer Institute, as well as the Duke Translational Medicine Institute.
Im deeply honored to become the next president of the IOM and recognize the critically important role that the IOM will have in improving the health of the nation at a time of extraordinary evolution in biomedical research and health care delivery, Dzau said in a press release from Duke University Health System. The explosion of new data resources, novel technologies and breathtaking research advances make this the most promising time in history for driving innovations that will improve health care delivery, outcomes and quality.
As the health sciences extension of the National Academy of Sciences, the Institute of Medicine is known for its leadership in advancing health sciences and objective medical research nationally as a nonprofit academic research organization. The outgoing IOM president, Dr. Harvey Fineberg (previously Dean of the Harvard School of Public Health) has lead the nonprofit for twelve years. His focus and research have centered around public health policy and an improvement in informed medical decision making.
This leaves the medical community wondering what Dr. Dzau will bring to the Institute.
As a former chairman of the Association of Academic Health Centers (AAHC), Dr. Dzau advocated for the innovative transition of academic medical and health centers into institutions that can survive the rapid transitions in the health care industry. In a recent article in the New England Journal of Medicine, Dr. Dzau discusses the uncertain future of academic medical centers. He argues that industry pressures and cost restraints from the Affordable Care Act limit the research and education-based missions of teaching hospitals.
See the original post here:
Duke Health System CEO appointed to head Institute of Medicine - Boston.com
Freeport, The Bahamas (PRWEB) February 21, 2014
Okyanos Heart Institute, whose mission it is to bring a new standard of care and a better quality of life to patients with coronary artery disease using adult stem cell therapy, announces CEO Matt Feshbach will present at the STEMSO Conference. He will join a panel to discuss the opportunities available through the new stem cell research and Therapy Act. The conference will be held at the Grand Lucayan Resort in Freeport, Grand Bahamas, February 19-22, 2014. The panel discussion will be Friday, February 21 from 8:45 9:45 a.m.
The conference, titled Bridging the Gap: Research to Point of Care, brings together medical scientists, clinicians, regulatory experts, and investors to discuss progress in the field of research and clinical protocols and the process of taking promising therapies to fight chronic disease to market in a responsible manner.
Friday opening remarks will be delivered by Ian Rolle, President of Grand Bahama Port Authority from 8:30 a.m. to 8:45 a.m. followed by the panel presentation until 9:45 a.m. which, in addition to Rolle will include Feshbach, Mitchell Fuerst, Esq., managing partner, Fuerst, Ittleman, David and Joseph. The panel will be moderated by Arthur K. Parris, Jr. of Parris Whittaker.
"With the passing of the Bahamas Stem Cell Research and Therapy Act, which requires high standards of patient safety and care, we believe the Bahamas is an ideal location to bring internationally-approved, adult stem cell technology to patients with unmet medical needs such as chronic coronary artery disease (CAD), says Feshbach. I am pleased to discuss the opportunities available in the Bahamas with investors, doctors and other stakeholders interested in making the Bahamas a world-class destination for adult stem cell therapy."
The STEMSO 2014 Conference in Freeport, Grand Bahama poses a unique opportunity for medical organizations which focus on adult stem cell-based medical treatments, states Douglas Hammond, president of STEMSO. This conference will provide companies looking to expand their research or clinical practices to offshore locations many good reasons to choose the Bahamas. Those attending will be able to network and view the most advanced research and clinical protocols utilizing autologous and allogeneic stem cells in the world today.
The complete agenda can be found on the organizations website at http://www.stemso.org. Other speakers include stem cell researchers, scientists and practitioners from around the world with leading discoveries in the field, and investors in the healthcare space.
Registration is open for attending and exhibiting on STEMSOs website.
ABOUT OKYANOS HEART INSTITUTE: (Oh key AH nos) Based in Freeport, The Bahamas, Okyanos Heart Institutes mission is to bring a new standard of care and a better quality of life to patients with coronary artery disease using cardiac stem cell therapy. Okyanos adheres to U.S. surgical center standards and is led by Chief Medical Officer Howard T. Walpole Jr., M.D., M.B.A., F.A.C.C., F.S.C.A.I. Okyanos Treatment utilizes a unique blend of stem and regenerative cells derived from ones own adipose (fat) tissue. The cells, when placed into the heart via a minimally-invasive procedure, can stimulate the growth of new blood vessels, a process known as angiogenesis. Angiogenesis facilitates blood flow in the heart, which supports intake and use of oxygen (as demonstrated in rigorous clinical trials such as the PRECISE trial). The literary name Okyanos, the Greek god of rivers, symbolizes restoration of blood flow. For more information, go to http://www.okyanos.com/.
NEW MEDIA CONTENT: Okyanos LinkedIn Page: http://www.linkedin.com/company/okyanos-heart-institute Okyanos Facebook Page: https://www.facebook.com/OKYANOS Okyanos Twitter Page: https://twitter.com/#!/OkyanosHeart Okyanos Google+ Page: https://plus.google.com/+Okyanos/posts Okyanos You Tube Physician Channel: http://www.youtube.com/user/okyanosforphysicians
New Stemcell Breakthrough Story on ABC15
Watch this story that ran on ABC 15 in Phoenix about how Arizona Pain is treating patients using stem cells. Check out our Stem Cell page: http://arizonapain...
By: Arizona Pain
FameLab Hong Kong 2014 Finalist: "Pluripotency - The power of stem cells" by Lo Lok Man
Subject: Pluripotency - The power of stem cells.
By: famelabhk
The rest is here:
FameLab Hong Kong 2014 Finalist: "Pluripotency - The power of stem cells" by Lo Lok Man - Video
Laminine Testimonial - Stroke
Laminine is availabe in the Philippines!!! "The Closest Alternative To Stem Cell Therapy..." "The miracle formula from a 9-day-old fertilized hen eggs" For M...
By: Julfran Ytang
Read the original:
Laminine Testimonial - Stroke - Video
Biology 07-6 Cell Differentiation and Stem Cells
This video explains the process of cell differentiation, the role of gene expression in this process, as well as the potential medical applications of stem c...
By: HollowayScience
Read more here:
Biology 07-6 Cell Differentiation and Stem Cells - Video
conversion of B lymphocytes into stem cells by a process of retrodifferentiation
conversion of leukemic B and T lymphocytes into stem cells by a process of retrodifferentiation. Lecture at the Physiology Department Downing College Cambrid...
By: Ilham Abuljadayel
More:
conversion of B lymphocytes into stem cells by a process of retrodifferentiation - Video